Next, we examined the sensitivity of these cell lines to TRAIL and found that siRNA-mediated knockdown of HIF-2α, but not HIF-1α, significantly decreased the cell viability of the TRAIL-treated three pancreatic cancer cell lines under hypoxic conditions (Figure 3b). Here, EPAS1 is linked to pancreatic neoplasm.